Critical Assessment of G Protein-Biased Agonism at the μ-Opioid Receptor: Trends in Pharmacological Sciences
Opioids in cancer: The κ‑opioid receptor (Review)
The Role of Opioids and Their Receptors in Urological Malignancy: A Review | Journal of Urology
Opioids in cancer: The κ‑opioid receptor (Review)
Hot topics in opioid pharmacology: mixed and biased opioids - British Journal of Anaesthesia
The relationship between the level of μ-opioid receptor (μORs) and postoperative analgesic use in patients undergoing septoplasty: a prospective randomized controlled trial | BMC Anesthesiology | Full Text
Structural Assessment of Agonist Efficacy in the μ-Opioid Receptor: Morphine and Fentanyl Elicit Different Activation Patterns | Journal of Chemical Information and Modeling
Opioids As Modulators of Cell Death and Survival—Unraveling Mechanisms and Revealing New Indications | Pharmacological Reviews
Opioid receptors beyond pain control: The role in cancer pathology and the debated importance of their pharmacological modulation - ScienceDirect
Scientists Just Solved a Major Piece of the Opioid Puzzle | WIRED
Nanobody-enabled monitoring of kappa opioid receptor states | Nature Communications
Cells | Free Full-Text | Role of NRF2 in Lung Cancer | HTML
Antagonists of the Mu-Opioid Receptor in the Cancer Patient: Fact or Fiction? | SpringerLink
A systematic review on the kappa opioid receptor and its ligands: New directions for the treatment of pain, anxiety, depression, and drug abuse - ScienceDirect
Kappa opioid receptor (KOR) modulation of dopamine in the cortex and... | Download Scientific Diagram
The impact of opioid receptor heterodimerization on opioid receptor... | Download Scientific Diagram
Novel Mixed NOP/Opioid Receptor Peptide Agonists | Journal of Medicinal Chemistry
Opioid receptor subtypes: fact or artifact? - British Journal of Anaesthesia
Effect of κ-opioid receptor agonist on the growth of non-small cell lung cancer (NSCLC) cells | British Journal of Cancer
Opioid Receptor | kappa, mu Opioid Receptor
Biased agonists of the kappa opioid receptor suppress pain and itch without causing sedation or dysphoria | Science Signaling
Untangling the complexity of opioid receptor function | Neuropsychopharmacology
Frontiers | Regulator of G-Protein Signaling (RGS) Protein Modulation of Opioid Receptor Signaling as a Potential Target for Pain Management
Effect of κ-opioid receptor agonist on the growth of non-small cell lung cancer (NSCLC) cells | British Journal of Cancer
A Kappa Opioid Receptor Agonist Blocks Bone Cancer Pain Without Altering Bone Loss, Tumor Size, or Cancer Cell Proliferation in a Mouse Model of Cancer-Induced Bone Pain - The Journal of Pain
